全文获取类型
收费全文 | 75315篇 |
免费 | 7168篇 |
国内免费 | 4572篇 |
专业分类
耳鼻咽喉 | 681篇 |
儿科学 | 1037篇 |
妇产科学 | 1120篇 |
基础医学 | 10045篇 |
口腔科学 | 1901篇 |
临床医学 | 8572篇 |
内科学 | 12386篇 |
皮肤病学 | 1088篇 |
神经病学 | 4977篇 |
特种医学 | 2821篇 |
外国民族医学 | 22篇 |
外科学 | 8687篇 |
综合类 | 10036篇 |
现状与发展 | 15篇 |
一般理论 | 14篇 |
预防医学 | 4902篇 |
眼科学 | 1876篇 |
药学 | 7460篇 |
28篇 | |
中国医学 | 3177篇 |
肿瘤学 | 6210篇 |
出版年
2024年 | 152篇 |
2023年 | 787篇 |
2022年 | 2031篇 |
2021年 | 2670篇 |
2020年 | 1976篇 |
2019年 | 1832篇 |
2018年 | 2217篇 |
2017年 | 1962篇 |
2016年 | 1845篇 |
2015年 | 2586篇 |
2014年 | 3288篇 |
2013年 | 3158篇 |
2012年 | 4505篇 |
2011年 | 4804篇 |
2010年 | 2947篇 |
2009年 | 2455篇 |
2008年 | 3420篇 |
2007年 | 3585篇 |
2006年 | 3425篇 |
2005年 | 3041篇 |
2004年 | 2585篇 |
2003年 | 2632篇 |
2002年 | 2317篇 |
2001年 | 3607篇 |
2000年 | 3368篇 |
1999年 | 3068篇 |
1998年 | 1528篇 |
1997年 | 1250篇 |
1996年 | 944篇 |
1995年 | 854篇 |
1994年 | 748篇 |
1993年 | 478篇 |
1992年 | 1326篇 |
1991年 | 1161篇 |
1990年 | 1047篇 |
1989年 | 1087篇 |
1988年 | 999篇 |
1987年 | 895篇 |
1986年 | 818篇 |
1985年 | 681篇 |
1984年 | 445篇 |
1983年 | 345篇 |
1982年 | 195篇 |
1981年 | 151篇 |
1980年 | 127篇 |
1979年 | 207篇 |
1978年 | 85篇 |
1973年 | 93篇 |
1972年 | 92篇 |
1971年 | 94篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Maria Ruden Christopher H. Olivares Mathew Q. Fakhoury Alicia Roston Patricia P. Vidal Courtney M.P. Hollowell Sarah P. Psutka 《Urologic oncology》2021,39(1):73.e19-73.e25
PurposeTo compare the clinical presentation, treatment receipt, and oncologic outcomes between human immunodeficiency virus-seropositive (HIV+) and seronegative (HIV?) men with prostate cancer (CaP) matched by age, clinical stage, and race.Materials and methodsA retrospective review of 3,135 men treated for CaP from 2000 to 2016 was performed. HIV+ patients (N = 46) were matched 1:2 to 3 to HIV? men (N = 137) by age, race, and clinical stage. Clinicopathologic features and primary treatment received were compared between cohorts. Associations between HIV status and progression-free, cancer-specific, and overall survival were compared by HIV status using the Kaplan-Meier method and Cox proportional hazards analysis.ResultsAfter matching, men with and without HIV were similar with respect initial prostate-specific antigen, Gleason Sum, and Eastern Cooperative Oncology Group (ECOG) performance status. Among HIV+ men, 67.4% had a history of acquired immune deficiency syndrome, and 91.3% were on highly active antiretroviral therapy at CaP diagnosis. Among men with localized disease, HIV+ men were more likely to receive radiation (59.5% vs. 44.8%) or no therapy (13.5% vs. 4.3%) and less likely to receive surgery (16.2% vs. 30.2%), or to initiate active surveillance (10.8% vs. 16.4%; P = 0.04 overall). There were no differences in rates of clinical progression, development of castration resistance, or CaP death by HIV status. However, HIV+ status was associated with inferior overall survival (hazard ratio 2.89, P = 0.04).ConclusionsWhile most HIV+ patients had a history of acquired immune deficiency syndrome; HIV was well controlled in the majority of patients at the time of CaP diagnosis. While oncologic outcomes were similar between HIV+ and HIV? men, significant differences in treatment selection were observed. Further research is necessary to understand differences in treatment election by HIV status and to define optimal CaP treatment selection in men with HIV. 相似文献
993.
Henry Seidel Sarah Bhattacharjee Sean Pirkle Lewis Shi Jason Strelzow Michael Lee Mostafa El Dafrawy 《The spine journal》2021,21(5):803-809
BACKGROUND CONTEXTCauda equina syndrome (CES) occurs due to compression of the lumbar and sacral nerve roots and is considered a surgical emergency. Although the condition is relatively rare, the associated morbidity can be devastating to patients. While substantial research has been conducted on the timing of treatment, the literature regarding long-term rates of bladder dysfunction in CES patients is scarce.PURPOSEThe aim of this study was to identify long-term rates of bladder dysfunction in CES patients and to compare those rates to non-CES patients who underwent similar spinal decompression.STUDY DESIGN/SETTINGRetrospective database study.PATIENT SAMPLEThe CES cohort was comprised of 2,362 patients who underwent decompression surgery following CES diagnosis with a 5-year follow-up. These patients were matched to 9,448 non-CES control patients who underwent spinal decompression without a diagnosis of CES.OUTCOME MEASURESDiagnosis of bladder dysfunction, surgical procedure to address bladder dysfunctionMETHODSUsing the national insurance claims database, PearlDiver, CES patients who underwent decompression surgery were identified and 1:4 matched to non-CES patients who underwent similar spinal decompression surgery. The 1-year, 3-year, and 5-year rates of progression to a bladder dysfunction diagnosis and surgical intervention to manage bladder dysfunction were recorded. The CES and non-CES groups were compared with univariate testing, and an analysis of risk factors for bladder dysfunction was performed with multivariate logistic regression analysis.RESULTSA total of 2,362 CES patients who underwent decompression surgery were identified and matched to 9,448 non-CES control patients. After 5 years, CES patients had a 10%–12% increased absolute risk of continued bladder dysfunction and a 0.7%–0.9% increased absolute risk of undergoing a surgical procedure for bladder dysfunction, as compared to matched non-CES patients. Multivariate analysis controlling for age, sex, obesity, tobacco use, and diabetes, identified CES as independently associated with increased 5-year risk for bladder dysfunction diagnosis (odds ratio [OR]: 1.72; 95% confidence interaval [CI] 1.56–1.89; p<.001) and procedure (OR: 1.40; 95% CI 1.07–1.81; p=.012).CONCLUSIONSUnderstanding the long-term risk for bladder dysfunction in CES patients is important for the future care and counseling of patients. Compared to non-CES patients who underwent similar spinal decompression, CES patients were observed to have a significantly higher long-term likelihood for both bladder dysfunction diagnosis and urologic surgical procedure. 相似文献
994.
Jiang Bian Ting Wang Jijun Sun Xiaozhen He Zhijiao Wu Songmei Zhang Hao Chi Tingting Fan Shaowen Wang Weiyun Shi Qingguo Ruan 《American journal of transplantation》2021,21(12):3858-3870
The relevance of Tregs in the induction of tolerance against corneal allografts has been well established. Although it is well known that the conversion of Tregs into effector-like cells contributes to the loss of corneal immune privilege, the underlying mechanism is still not fully understood. Using heterologous penetrating keratoplasty model, we found that Tregs from corneal allograft rejected mice (inflam-Tregs) exhibit impaired function and characteristics of effector T cells. Further study showed that the expression of NF-κB c-Rel, a key mediator of effector T cell function, was significantly increased in inflam-Tregs. Mechanistic study revealed that elevated NF-κB c-Rel level in inflam-Tregs impaired Treg function through the promotion of inflammatory cytokine production and glycolysis. More importantly, we demonstrated that targeting NF-κB c-Rel was able to improve the immune suppressive function of inflam-Tregs in vitro and enhance the potential of them to suppress corneal transplantation rejection. Therefore, our current study identified NF-κB c-Rel as a key mediator of the conversion of Tregs into effector-like cells when under inflammatory environment. 相似文献
995.
996.
997.
目的 探索我国中老年人共病发展轨迹及其对新发失能的影响,以识别具有相似共病发展历程的同质群体,为我国中老年人群的失能风险干预提供依据。方法 基于中国健康与养老追踪调查2011-2018年4期数据,采用组基轨迹模型拟合共病发展轨迹,进而采用含时间依存协变量Cox回归模型分析其对新发失能的影响。结果 共纳入8 580名中老年人,依据中老年共病发展轨迹趋势,可分为无共病型(2 136人,24.90%)、新发-发展型(3 758人,43.80%)、适度-发展型(2 270人,26.45%)和严重-发展型(416人,4.85%)4种类型。适度-发展型和严重-发展型人群中女性、自评健康差、超重/肥胖、单身、居住在农村、家庭年人均支出水平高、发生新发失能的占比较高。调整人口学、行为学协变量后,与新发-发展型相比,严重-发展型(HR=3.132,95%CI:1.884~5.207)的失能风险最高,适度-发展型(HR=1.400,95%CI:1.026~1.909)次之,无共病型(HR=0.631,95%CI:0.424~0.938)最低。结论 我国中老年人的共病发展轨迹存在异质性,共病发展轨迹的失能风险随共病水平的升高而增加,提示共病发展轨迹升高是发生失能的危险因素。 相似文献
998.
目的 分析北京市海淀区一起新型冠状病毒肺炎聚集性疫情流行病学特征及传播链。方法 采用描述性流行病学方法分析疫情流行病学特征,应用现场调查和大数据技术分析传播链。结果 2022年4月27日至5月13日, 海淀区发生一起新型冠状病毒肺炎聚集性疫情,全基因组测序系Omicron变异株(BA.2.2进化分支);涉及感染者38例,确诊病例34例,无症状感染者4例;临床分型以轻型(88.2%)为主,无重型、危重型和死亡病例;早期临床症状以咽部不适(50.0%)、咳嗽(29.4%)为主;17 d内传播7代,涉及3起社区聚集、2起单位聚集和8个家庭内传播;暴露方式以同住(47.6%)、同时空暴露(31.6%)为主;代间距M(Q1,Q3)为3(1,6)d;总续发率为1.5%(37/2 482),其中家庭续发率为36.7%(18/49)。结论 本起Omicron变异株疫情临床症状轻,家庭、社区聚集性明显,疫情传播速度较快,同时空暴露感染风险较高,需利用信息化技术全面摸排密切接触者,以快制快,有效阻断疫情传播。 相似文献
999.
目的 探索户外时间对小学生近视发生的影响,并评估其在不同年级学生中的差异,为预防近视相关政策制定提供依据。方法 本研究基于队列研究设计,在2019年调查了江苏、上海、福建、山西、河南、湖南、甘肃、重庆、广西9个省(自治区、直辖市)6 046名1~5年级小学生,现场对其近视情况进行检查,并在2020年对该群体再次进行随访,现场检测近视发生情况,并在2020年视力测量后一周内对近视相关行为进行问卷调查。采用χ2检验、Cochran-Armitage趋势检验比较组间差异,采用Cox比例风险回归模型检验户外时间与近视发生的关系。结果 在2020年,基线时为1~5年级的小学生近视发生率为27.5%,其中,1~2年级小学生近视发生率为23.0%,3~5年级小学生近视发生率为31.7%。控制协变量后,在1~2年级小学生中,平均每天户外时间≥1 h学生近视发生风险是平均每天户外时间<1 h学生的0.76倍(95%CI:0.62~0.93,P=0.008);而对于3~5年级小学生,平均每天户外时间≥3 h才对近视发生有显著保护作用,其近视发生风险是平均每天户外时间<3 h学生的0.75倍(95%CI:0.61~0.93,P=0.007)。结论 1~2年级小学生平均每天达到1 h户外时间可以降低近视发生率,而3~5年级小学生平均每天需达到3 h户外时间可能才会有效降低近视发生率。因此,针对不同年级小学生预防近视的户外时间推荐应有差异,年级越高,户外时间相应增加,降低其近视发生率。但同时,还要关注其他因素对近视的作用,采用综合手段防控近视的发生。 相似文献
1000.
Yifeng Ren Mengling Wei Hong Liu Yao Wang Hairuo Chen Zhuohong Li Wei Shi Fengming You 《International wound journal》2021,18(1):32-48
To further identify the real efficacy and safety of dexmedetomidine as an adjuvant to local wound infiltration anaesthesia, we conducted this meta-analysis. The systematic search strategy was performed using PubMed, Embase, Cochrane Library, and Chinese databases. As a result, a total of 23 RCTs (1445 patients) were included. Patients receiving dexmedetomidine combined with local anaesthetics had a lower rescue analgesia rate [risk ratio (RR): 0.48; 95% confidence interval (CI): 0.36-0.65] and lower rescue analgesic consumption [weighted mean difference (WMD): −10.80 mg; 95%CI: −13.28 to −8.31 mg] than patients receiving local anaesthetics alone. The dexmedetomidine-related adverse reactions included bradycardia (RR: 1.33; 95%CI: 0.32-5.56) and hypotension (RR: 3.00; 95%CI: 0.49-18.42). In addition, the time to first analgesic request (WMD: 296.16 minutes; 95%CI: 165.69 minutes ~ 426.63 minutes), incidence of postoperative nausea and vomiting (PONV) and pain scores at 4 hours postoperatively were also significantly lower in patients receiving dexmedetomidine combined with local anaesthetics. This meta-analysis demonstrated that the use of dexmedetomidine as an adjuvant to wound infiltration is effective for reducing the rescue analgesia rate, rescue analgesic consumption and PONV. In addition, limited evidence shows that dexmedetomidine can prolong postoperative analgesia for approximately 5 hours. Further investigations on dexmedetomidine-related adverse reactions and the dose–response effect of dexmedetomidine in wound infiltration are warranted. 相似文献